A. Schäfer, F. Muecksch, J. C. Lorenzi, S. Leist, M. Cipolla, S. Bournazos, F. Schmidt, R. Maison, A. Gazumyan, D. R. Martinez, R. Baric, D. Robbiani, T. Hatziioannou, J. Ravetch, P. Bieniasz, R. Bowen, M. Nussenzweig, T. Sheahan
The Journal of experimental medicine, 2021
Human monoclonal antibody potency in vitro does not uniformly correlate with its in vivo neutralization of SARS-CoV-2. Antibody Fc-effector function is important for in vivo neutralization, and antibody combinations show superior efficacy compared with single antibodies.
Cited by 88 publications.
Field of study: Medicine